Nanoparticle technologies for cancer therapy

Area of Science:

• Biomedical Engineering
• Oncology
• Materials Science

Background:

• Nanoparticles have emerged as crucial tools in cancer therapy over the past 20 years.
• Existing clinical nanoparticle formulations include liposomes, polymer-drug conjugates, and micelles.
• Numerous nanoparticle platforms are progressing through preclinical development.

Purpose of the Study:

• To review preclinical and clinical nanoparticle technology platforms for cancer therapy.
• To highlight the impact of these advanced delivery systems on cancer treatment.
• To discuss the potential of multifunctional nanoparticles in addressing complex cancer challenges.

Main Methods:

• Review of existing literature on nanoparticle drug delivery systems.
• Analysis of preclinical and clinical data for various nanoparticle platforms.
• Examination of emerging nanoparticle technologies incorporating targeting and multifunctionality.

Main Results:

• A wide array of nanoparticle systems, both organic and inorganic, have been developed.
• Several nanoparticle formulations are currently in clinical use, with more in preclinical stages.
• Newer nanoparticles exhibit enhanced sophistication with multifunctional capabilities and targeting strategies.

Conclusions:

• Nanoparticle drug delivery systems represent a significant advancement in cancer treatment.
• Multifunctional nanoparticles offer potential solutions for drug resistance and metastatic disease.
• Continued development of nanoparticle platforms is crucial for improving cancer therapy efficacy.